Literature DB >> 19091344

Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography.

Tatum V Tarin1, Geoffrey Sonn, Rajesh Shinghal.   

Abstract

PURPOSE: Computerized tomography has a critical role in the surveillance of stage I nonseminomatous germ cell tumors of the testis. Some protocols call for up to 16 computerized tomography scans over 5 years, thereby exposing young patients to a significant amount of radiation. We estimated the lifetime risk of cancer incidence and cancer death from imaging related radiation received during surveillance of stage I nonseminomatous germ cell tumor.
MATERIALS AND METHODS: Using a model with a 64-slice computerized tomography scanner obtaining images of the abdomen and pelvis with or without chest in a standardized, phantom male patient, organ specific radiation doses were estimated using Monte Carlo simulation techniques. Lifetime attributable risks of cancer were estimated using the approach outlined in the Biological Effects of Ionizing Radiation VII Phase 2 report.
RESULTS: With a 5-year surveillance protocol as suggested by the National Comprehensive Cancer Network, lifetime cancer risk ranged from 1 in 52 (1.9%) for an 18-year-old to 1 in 63 for a 40-year-old patient (1.2%). If chest computerized tomography is also performed the risk increases to 1 in 39 (2.6%) and 1 in 85 (1.6%), respectively. Lung and colon cancer accounted for most of the risk. The relative risk of a secondary malignancy with surveillance compared to a single scan after retroperitoneal lymph node dissection is approximately 15.2.
CONCLUSIONS: Computerized tomography used in testicular cancer surveillance protocols imparts large radiation doses and is associated with a significant risk of cancer. This risk should be factored into counseling patients with stage I nonseminomatous germ cell tumor.

Entities:  

Mesh:

Year:  2008        PMID: 19091344     DOI: 10.1016/j.juro.2008.10.005

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  44 in total

1.  Testicular cancer: Decision tree model has potential to improve NSGCT management.

Authors:  Ornob P Roy; Louis R Kavoussi
Journal:  Nat Rev Urol       Date:  2010-06       Impact factor: 14.432

Review 2.  Cancer risk related to gastrointestinal diagnostic radiation exposure.

Authors:  Mimi L Chang; Jason K Hou
Journal:  Curr Gastroenterol Rep       Date:  2011-10

3.  High-risk clinical stage I NSGCT: the case for RPLND.

Authors:  Christopher Morash; Ilias Cagiannos
Journal:  World J Urol       Date:  2009-06-02       Impact factor: 4.226

Review 4.  Critical evaluation of modified templates and current trends in retroperitoneal lymph node dissection.

Authors:  Shane Pearce; Zoe Steinberg; Scott Eggener
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

Review 5.  Current Concepts in Management of Stage I NSGCT.

Authors:  Puneet Ahluwalia; Gagan Gautam
Journal:  Indian J Surg Oncol       Date:  2016-12-17

Review 6.  Retroperitoneal lymph node dissection: an update in testicular malignancies.

Authors:  K Yadav
Journal:  Clin Transl Oncol       Date:  2017-02-01       Impact factor: 3.405

7.  Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma.

Authors:  Charles B Simone; Kevin Kramer; William P O'Meara; Justin E Bekelman; Arnaud Belard; James McDonough; John O'Connell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-13       Impact factor: 7.038

Review 8.  Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.

Authors:  Aadel A Chaudhuri; Michael S Binkley; Evan C Osmundson; Ash A Alizadeh; Maximilian Diehn
Journal:  Semin Radiat Oncol       Date:  2015-05-15       Impact factor: 5.934

9.  Patients with testicular cancer undergoing CT surveillance demonstrate a pitfall of radiation-induced cancer risk estimates: the timing paradox.

Authors:  Pari V Pandharipande; Jonathan D Eisenberg; Richard J Lee; Michael E Gilmore; Ekin A Turan; Sarabjeet Singh; Mannudeep K Kalra; Bob Liu; Chung Yin Kong; G Scott Gazelle
Journal:  Radiology       Date:  2012-12-18       Impact factor: 11.105

10.  Clinical outcomes in patients with stage I non-seminomatous germ cell cancer.

Authors:  Zhao-Jie Lv; Song Wu; Pei Dong; Kai Yao; Yin-Yin He; Yao-Ting Gui; Fang-Jian Zhou; Zhuo-Wei Liu; Zhi-Ming Cai
Journal:  Asian J Androl       Date:  2013-05-20       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.